Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma insulin concentrations such as those observed during the present insulin/glucose or glucose infusion studies, are known to completely suppress hepatic glucose production (27); thus, under these conditions, total glucose uptake is equal to exogenous glucose infusion.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [27]
In the citing paper
“Notably, insulin resistance is also associated with a decreased ability to suppress lipolysis in adipose tissue and altered fatty acid oxidation.50,51”
From The effects of sleep disruption on metabolism, hunger, and satiety, and the influence of psychosocial stress and exercise: A narrative review (2024) · cites this paper as [51]
In the citing paper
“In lean healthy individuals insulin stimulates glucose uptake into skeletal muscle in a dose-dependent manner, with a half-maximal effect (EC50) at a plasma insulin concentration ~60 μU/mL [21].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“Using the gold standard euglycemic hyperinsulinemic clamp technique to quantify insulin-stimulated glucose uptake, they demonstrated that both lean and obese T2DM subjects have marked decrease (>50%) in whole body glucose disposal during the insulin clamp.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“During the postabsorptive state, the plasma insulin concentration is low. Since the plasma insulin concentration is the principal factor that restrains lipolysis in adipocytes [21] and stimulates glucose uptake in skeletal muscle [21], during the fasting state, muscle glucose uptake is low and the plasma FFA concentration is elevated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“More than 20 years ago Randle and co-workers introduced the concept of substrate competition, whereby enhanced availability and oxidation of FFA leads to an impairment in glucose oxidation (17).”
BackgroundImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Since CPT I is inhibited by both insulin and malonyl-CoA, which is generated by condensation of acetyl-CoA (56), the insulin-mediated decline in FFA oxidation could have been due to a direct effect of the hormone on CPT I.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 2×
“in insulin-mediated glucose metabolism affects both hepatic and peripheral tissues, primarily muscle (1-6).”
BackgroundSelf-citationEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationRadioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Cited by
Items 601–700 of 812
Improving oral pharmacologic treatment and management of type 2 diabetes.
Ge, D. (2004) · PubMed · Cited by 10
Analysis of Insulin Resistance in Nonalcoholic Steatohepatitis
Kim, H., Zhang, D., Song, Z., Tong, X., & Zhang, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2128-8_18 · Cited by 8
Won, J. C. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_11 · Cited by 12
Lee, K. J., & Ji, G. E. (2014) · Journal of Ginseng Research · doi:10.1016/j.jgr.2013.12.003 · Cited by 12
“During the overnight fasting period, the burst size of FFA during the daily cycle is maximized [7].”
BackgroundAssociations between Liver Enzyme Levels and Parameters of the Metabolic Syndrome in Obese Children
Hampe, C. S., Shaffer, M. L., & Roth, C. L. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479868 · Cited by 9
Insulin Treatment in Type 2 Diabetes
Ryysy, L. (2001) · Helda - University of Helsinki Institutional Repository · Cited by 9
Non-esterified fatty acids are related with hypofibrinolysis in type 2 diabetes mellitus
Brussaard, H. E., Leuven, J. A. G., Krans, H. M. J., Meijer, P., Buytenhek, R., & Kluft, C. (1994) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(94)90235-6 · Cited by 9
The Genetics and Pathophysiology of Type II and Gestational Diabetes
Csorba, T. R., Edwards, A. L., & Tan, M. H. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509082593 · Cited by 10
Chung, J. O., Koutsari, C., Blachnio-Zablieska, A. U., Hames, K. C., & Jensen, M. D. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2017 · Cited by 8
“Skeletal muscle takes up FFA in the postabsorptive state (12, 20) and switches the predominant fuel source from fatty acids to glucose in the postprandial state (13).”
BackgroundCOVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management
Zhang, S., Wu, Y., Mprah, R., & Wang, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1434331 · Cited by 9
Voigt, J. H., Lauritsen, K. M., Pedersen, S. B., Hansen, T. K., Møller, N., Jessen, N., LAURENTI, M. C., Man, C. D., Vella, A. V., Gormsen, L. C., et al. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13991 · Cited by 9
“Furthermore, Hawkins et al. 33 showed that restoring euglycaemia for 72 h in a group of people with T2D with hyperglycaemia completely restored GE.”
BackgroundInfluentialArnetz, L., Ekberg, N. R., Höybye, C., Brismar, K., & Alvarsson, M. (2013) · ISRN Endocrinology · doi:10.1155/2013/148497 · Cited by 8
Palmitate exacerbates bisphenol A toxicity via induction of ER stress and mitochondrial dysfunction
Mondal, A., Burchat, N., & Sampath, H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158816 · Cited by 10
Insulin-mediated muscle microvascular perfusion and its phenotypic predictors in humans
Love, K. M., Jahn, L. A., Hartline, L. M., Patrie, J. T., Barrett, E. J., & Liu, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-90935-8 · Cited by 8
Marcotte‐Chénard, A., & Little, J. P. (2024) · Translational Exercise Biomedicine · doi:10.1515/teb-2024-2007 · Cited by 14
“However, in the presence of IR, the ability of insulin to inhibit lipolysis is impaired, resulting in a sustained increase in plasma free fatty acid (FFA) [45].”
Cavallo‐Perin, P., Bruno, A., Cassader, M., CESCO, L., Gruden, G., & Pagano, G. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01436.x · Cited by 8
Metformin and Other Biguanides: Pharmacology and Therapeutic Usage
Garber, A. J. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0610 · Cited by 9
Hazari, M. A., Kannan, G., Dasgupta, S., Pavan, M. K., Jha, A. K., Sultana, F., Pujahari, S. R., Singh, S., Dutta, S., Pydi, S. P., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c15698 · Cited by 8
Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk
Prakash, S., Choudhury, P., & Bisht, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1683159 · Cited by 7
Dave, T. V., Nair, A. G., Joseph, J., & Freitag, S. K. (2022) · Orbit · doi:10.1080/01676830.2022.2099428 · Cited by 8
“This can lead to impaired glycemic control in patients with COVID-19.”
BackgroundInfluentialErrors in measuring plasma free fatty acid concentrations with a popular enzymatic colorimetric kit
Song, Y., Zhou, L., & Jensen, M. D. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.01.008 · Cited by 10
Regulation of Intermediatory Metabolism During Fasting and Feeding
DeFronzo, R. A., & Ferrannini, E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00036-8 · Cited by 7
Self-citationPathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_9 · Cited by 10
Tayek, J. A. (1995) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199503000-00003 · Cited by 7
Rationale and hurdles of inhibitors of hepatic gluconeogenesis in treatment of diabetes mellitus
Kashiwagi, A. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01079-s · Cited by 7
de Kreutzenberg, S. V., RICCIO, A., Dorella, M., Avogaro, A., Marescotti, M. C., Tiengo, A., & Prato, S. D. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01714.x · Cited by 7
Stümvoll, M., Wahl, H. G., Jacob, S., Rettig, A., Machicao, F. E., & Häring, H. U. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31504-2 · Cited by 9
RetractedPharmacological variability of insulins degludec and glargine 300 U/mL: Equivalent or not?
Monnier, L., & Colette, C. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.11.001 · Cited by 7
Insulin actions in vivo : glucose metabolism
Ferrannini, E., & DeFronzo, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch14 · Cited by 12
Self-citationNakamura, J., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Minami, S., Sakai, S., Yonishi, H., Maeda, S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.184451 · Cited by 11
“When circulating FFAs are derived from adipose tissue, as in fasting or insulin-resistant conditions, the proximal tubules uptake FFAs and form LDs (15, 82).”
Gonzalez, J. T., Lolli, L., Veasey, R. C., Rumbold, P. L. S., Betts, J. A., Atkinson, G., & Stevenson, E. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03467-y · Cited by 10
“Second, suppression of adipose tissue lipolysis is highly sensitive to insulin such that in most postprandial situations adipose tissue lipolysis is maximally suppressed [2, 44 ], thereby resulting a “floor” effect.”
BackgroundJeyakumar, S., Reddy, M. R. G., Garlapati, C., Reddy, S. D., & Vajreswari, A. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100831 · Cited by 6
PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway
Wang, P., Jin, C., Liu, C. X., Zhao, Z.-J., & Yang, H. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/1456187 · Cited by 6
RetractedKadowaki, S., Tamura, Y., Sugimoto, D., Kaga, H., Suzuki, R., Someya, Y., Yamasaki, N., Sato, M., Kakehi, S., Kanazawa, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124084 · Cited by 9
“parallel with serum insulin concentrations [38]; therefore, Rd during the second step was divided by SSSI.”
MethodRegional disposal of intravenously infused glucose during prolonged hyperglycemia–hyperinsulinemia
Sidossis, L. S., Mittendorfer, B., Walser, E., & Wolfe, R. R. (1999) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(99)00043-1 · Cited by 7
Antihyperglycaemic Activity of Six Edible Plants in Validated Animal Models of Diabetes Mellitus
Mishra, A., Jaitly, A. K., & Srivastava, A. K. (2009) · doi:10.17485/ijst/2009/v2i4/29437 · Cited by 6
Doiron, B., Hu, W., & DeFronzo, R. A. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666151223124031 · Cited by 6
Self-citationAlmquist, J. O., Hovdal, D., Ahlström, C., Fjellström, O., Gennemark, P., & Sundqvist, M. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.022 · Cited by 6
“…of non-esterified fatty acids (NEFA) and triglycerides are often observed in patients with type 2 diabetes mellitus (T2DM) (DeFronzo, 2004; Paolisso et al., 1995; Reaven and Greenfield, 1981) and are strongly associated with insulin resistance (Boden, 1997; Groop et al., 1989; Groop et al., 1991).”
BackgroundHirayama, S., Hori, A., Isshiki, M., Hirayama, A., Ueno, T., Tamura, Y., Kaga, H., Watada, H., Kawamori, R., & Miida, T. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.06.003 · Cited by 7
Kuhre, R. E., Deacon, C. F., Albrechtsen, N. J. W., & Holst, J. J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14422 · Cited by 8
Hassoun, S., Al-Atrash, M., Al-Kasim, M. A., Dabbous, Z., Mujahed, O., DeFronzo, R. A., Jayyousi, A., Zirie, M. A., & Abdul‐Ghani, M. A. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.11.002 · Cited by 6
Self-citationYost, T. J., Sadur, C. N., & Eckel, R. H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90149-3 · Cited by 6
Metabolic Disturbances in Diabetes
Vella, A. V., & Rizza, R. A. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch13 · Cited by 5
Moreno‐Ulloa, A., & Moreno-Ulloa, J. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.04.018 · Cited by 6
“Aside from insulin resistance, individuals with type 2 diabetes may manifest other pathophysiologic abnormalities such as: adipocyte insulin resistance [5], impaired incretin effect [6], increased glucagon secretion and enhanced hepatic sensitivity to glucagon [7,8], increased renal glucose reabsorption [9], and brain…”
BackgroundZheng, Y., Wang, J., Ding, X., Chen, S., Li, J., & Shen, B. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s368568 · Cited by 5
“The liver and skeletal muscle are primarily responsible for insulin-induced glucose disposal, and their function will be influenced by a large number of inflammatory cells and inflammatory factors.(30) It has been reported that COVID-19 patients have a diffuse alveolar injury, inflammatory cell infiltration in lung an…”
BackgroundCapell, W. H., Schlaepfer, I. R., Wolfe, P., Watson, P. A., Bessesen, D. H., Pagliassotti, M. J., & Eckel, R. H. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00618.2009 · Cited by 6
“Our C2/LPL myoblasts have some characteristics reported previously in insulin-resistant states such as increased myocellular lipid accumulation, increased non-insulin-mediated glucose uptake (4, 10, 18), decreased Akt phosphorylation (2, 46), and decreased hexokinase II expression (5, 34).”
BackgroundAlipour, M., Javeshghani, D., & Roustazadeh, A. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201039 · Cited by 5
Pathogenesis of Insulin Resistance
Zaman, G. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92864 · Cited by 8
“There has been consistent demonstration of weakened suppression of plasma FFA and also glycerol and 14C-palmitate turnover with the stepped hyperinsulinemic clamp [106, 110, 111] (i.”
BackgroundTokuyama, K., Nagasaka, S., Mori, S., Takahashi, N., Kusaka, I., Kiyonaga, A., Tanaka, H., Shindo, M., & Ishibashi, S. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0011 · Cited by 5
“15,16 Second, in accordance with the indirect action of insulin, suppression of EGP by insulin in this model is described in terms of peripheral insulin action [ x ( t ) ¼ k c I 0 ( t )].”
Effect of misoprostol (PGE1) on glucose metabolism in type‐2‐diabetic and control subjects
Lee, N. A., Matsuda, M., Bressler, P. B., Pratipanawatr, T., Glass, L. C., Mandarino, L. J., & DeFronzo, R. A. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00203.x · Cited by 5
Self-citationZhao, H., Liu, L., Sui, Y., Ho, S. K. S., Tam, S.-K., Lai, F. M., Chan, J. C. N., & Tong, P. C. Y. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0225-1 · Cited by 6
“In type 2 diabetes, free fatty acids/lipid and glucose metabolism are interrelated with insulin resistance [ 16 ].”
BackgroundDeFronzo, R. A. (2003) · The British Journal of Diabetes · doi:10.1177/1474651403003001s0601 · Cited by 5
Self-citationJohnson, A. B., & Taylor, R. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.782.1010 · Cited by 7
Riemens, S. C., Dullaart, R. P. F., Franssen, J. F., Piers, D. A., Reitsma, W. D., & Sluiter (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00249.x · Cited by 4
Pathogenesis of Type 2 Diabetes
Cusi, K. J., & DeFronzo, R. A. (2001) · Wiley eBooks · doi:10.1002/cphy.cp070237 · Cited by 8
Self-citationAre there sex differences in the variability of fasting metabolism?
Bradshaw, L., Buniam, J., Betts, J. A., & Gonzalez, J. T. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00053.2024 · Cited by 5
Jamwal, J., Chhabra, A., Qadir, A., Ganie, M. A., Qadri, S. M., Lone, A., & Shah, N. N. (2024) · Endocrine · doi:10.1007/s12020-024-04006-9 · Cited by 7
“Acute viral respiratory infections and the rapid onset of transient insulin resistance due to increase in proin fl ammatory cytokines and immune dysfunction leading to decreased glucose disposal at level of skeletal muscle and liver has already been documented in literature [33 – 35].”
Corcillo, A., Saqib, A., Sithamparanathan, N., Khanam, A., Williams, J., Gulati, A., Kariyawasam, D., & Karalliedde, J. J. (2022) · International Journal of Endocrinology · doi:10.1155/2022/8030765 · Cited by 4
“*e impact of SARS-CoV-2 on pathways that drive insulin resistance has been described, and this may explain the raised insulin requirements in the acute phase of the infection by SARS-CoV-2 andwhy thismay fall as the infection resolves with subsequent clinical improvement [30, 31].”
BackgroundSchleh, M. W., Ryan, B. J., Ahn, C., Ludzki, A. C., Pelt, D. W. V., Pitchford, L. M., Chugh, O. K., Luker, A. T., Luker, K. E., Samovski, D., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14249 · Cited by 5
Management of Type 2 Diabetes Mellitus
Marks, J. B. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_8 · Cited by 5
“In order, and all statistically signifi cant, the variables were low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, A 1C , and systolic blood pressure (SBP) [ 10 ] (see Fig.”
BackgroundNAFLD and Insulin Resistance: A Multisystemic Disease
Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4
Wang, H.-D., Zhang, C., Li, M., Lin, Q., Zhang, Q., Liu, D., Ma, Z., & Dong, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.708139 · Cited by 6
Obesity and Glucose Metabolism
Napoli, N., & Pozzilli, P. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_11 · Cited by 4
Wium, C., Aasheim, E. T., Ueland, T., Michelsen, A. E., Thorsby, P. M., Larsen, I. F., Torjesen, P. A., Aukrust, P., & Birkeland, K. I. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-49 · Cited by 4
Hupfeld, C. J., & Olefsky, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00040-8 · Cited by 9
Si l'ère des insulines semi-synthétiques et biosynthétiques nous était contée
Monnier, L., Colette, C., & Owens, D. R. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(21)00178-4 · Cited by 5
Bedtime Dosing of Glyburide and the Treatment of Type II Diabetes Mellitus
Hennessey, J. V., Bustamante, M. A., Teter, M. L., Markert, R. J., & McDonald, S. D. (1994) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199430840-00004 · Cited by 4
Measured Versus Predicted Resting Metabolic Rate in Obese Diabetic and Obese Non-Diabetic Subjects
Merghani, T. H. (2013) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-01026367 · Cited by 4
“One of these mechanisms is an increase in gluconeogenesis [24].”
BackgroundMitochondrial Dysfunction in Type 2 Diabetes—An Update
Abdul‐Ghani, M. A., DeFronzo, R. A., & Medicine, A. P. O. (2009) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2009.05.00.28 · Cited by 4
Self-citationO’Callaghan, S. (2016) · Physician Assistant Clinics · doi:10.1016/j.cpha.2016.08.003 · Cited by 6
Migraine in Patients with Metabolic Syndrome: Is there a Relationship to Leptin?
Hamed, S. A. (2012) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000114 · Cited by 4
“Several studies reported an association between migraine and MS and its different components as obesity (TBO and abdominal adiposity) [10-13], poor glycemic control [14], IR [15], HTN [16] and hypercholesterolemia/dyslipidemia [17].”
BackgroundManagement of Type 2 Diabetes Mellitus: Defining the Role of Nateglinide
Carswell, C., Culy, C. R., & Perry, C. M. (2002) · Disease Management & Health Outcomes · doi:10.2165/00115677-200210060-00006 · Cited by 4
Misunderstanding in the classification of diabetes mellitus. What's in a name?
Elks, M. L., & Sawyer, J. W. (1993) · PubMed Central · Cited by 8
Oral Antidiabetic Drugs in Research and Development
Bischoff, H., & Lebovitz, H. E. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-09127-2_23 · Cited by 4
Henderson, G. C. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.07.019 · Cited by 3
Nutrient and non-nutrient regulators of insulin secretion
Kolic, J., Assaf, N., & Johnson, J. D. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01281-6 · Cited by 8
“Even small differences in basal secretion can lead to inappropriate hepatic glucose production and insulin resistance, ultimately contributing to fasting hyperglycaemia 47 .”
Pathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_8 · Cited by 4
The Role of Plasma Non‐esterified Fatty Acids During Exercise in Type 2 Diabetes Mellitus
Berrish, T. S., Elliott, C., Cooper, B. G., Reed, J. W., Ørskov, H., Alberti, K. G. M. M., & Walker, M. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00033.x · Cited by 3
Insulin-related metabolic and endocrine effects of valproate in patients with epilepsy
Pylvänen, V. (2005) · Cited by 4
Hupfeld, C. J., Courtney, C. H., & Olefsky, J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00041-1 · Cited by 7
“Hepatic glucose production can be suppressed completely by high physiologic or supraphysiologic insulin levels in type 2 diabetes, but the sensitivity of HGO to lower concentrations of insulin is reduced.(12) This reduced insulin sensitivity also contributes to the overall increase in glucose production in these patie…”
BackgroundSerotonin alters the response to a glucose challenge in lactating cows
Pszczolkowski, V. L., Connelly, M. K., Beard, A. D., Benn, A. D., Laporta, J., Hernandez, L. L., & Apelo, S. I. A. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0280 · Cited by 4
Bai, Y., Tang, X.-Q., Wu, Y., Yang, Y., Yu, X., Chen, J., Xue, X., & Kang, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.103954 · Cited by 4
Early metabolic defects in Arab subjects with strong family history of Type 2 diabetes.
Shalata, A., Jazmawi, W., Aslan, O., Badarni, K., Dabbah, K., Sawaed, S., Castel, O. C., Borochowitz, Z. U., Karkabi, K., DeFronzo, R. A., et al. (2013) · PubMed · doi:10.3275/8762 · Cited by 4
Self-citationFoo, M., Coppack, S. W., Denver, A. E., Bulmer, K., & Yudkin, J. S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12595 · Cited by 3
Insulin resistance and metabolic parameters in type 2 diabetic patients
Metzler, W., Fischer, S., Köhler, C. U., Pistrosch, F., Kindel, B., & Hanefeld, M. (2002) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(01)00202-3 · Cited by 3
Pathogenesis of Type 2 Diabetes—A Comprehensive Analysis
Unger, J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00003-6 · Cited by 3
PERKEMBANGAN TERAPI DIABETES MELLITUS TIPE 2 PADA PASIEN YANG TERINFEKSI COVID-19
Balqis, A. Y., Ramdhani, H., & Amelia, E. K. (2021) · Journal of Experimental and Clinical Pharmacy (JECP) · doi:10.52365/jecp.v1i2.244 · Cited by 3
Role of insulin action in the pathogenesis of diabetic complications
Tsuchiya, K. (2022) · Diabetology International · doi:10.1007/s13340-022-00601-1 · Cited by 3
“The indices of systemic and adipose insulin resistance [55, 56], namely, homeostasis model assessment-estimated insulin resistance (HOMA-IR) and adipose tissue insulin resistance (Adipo-IR), respectively, were significantly reduced upon CANA treatment.”
BackgroundPathophysiology of Insulin Action in Humans
Prato, S. D. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50011-5 · Cited by 3
Eshiet, E. R. (2010) · ThinkTech (Texas Tech University) · Cited by 3
Metabolic Disturbances in Diabetes
Vella, A. V., & Rizza, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch15 · Cited by 3
A single nuclei atlas of aging human abdominal subcutaneous white adipose tissuePreprint
Sparks, L. M., Whytock, K. L., Divoux, A., Sun, Y., Pino, M., Yu, G., Smith, S. R., & Walsh, M. J. (2023) · Research Square · doi:10.21203/rs.3.rs-3097605/v1 · Cited by 3
Wlazlo, N. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140514nw · Cited by 3
Beattie, C. E., Borislava, B., Smith, H., Ambler, M. T., White, P., Milne, D., Ramesh, A. V., Ferriman, A., Fisher, T., Horsley, C., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.10.003 · Cited by 2
“…glucose concentrations both directly (via suppression of endogenous glucose production and stimulation of peripheral glucose uptake) and indirectly, via suppression adipose tissue lipolysis and thereby reduced competition for mitochondrial substrate oxidation between glucose and fatty acids [38].”
Lee, S. R., Mukae, M., Kim, G., Park, J., Sung, Y. H., Won, Y. S., Kim, T., Kwun, H., Baek, I., & Hong, E. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70121 · Cited by 2
“First, impaired glucose clearance due to decreased skeletal muscle mass itself has been directly associated with T2D development [6, 7].”
Laitinen, A., Käräjämäki, A., Käräjämäki, A. J., Kurki, S. H., Hakaste, L., Asplund, O., Hultman, J., Lahti, K., Lehtovirta, M., Ahlqvist, E., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70983 · Cited by 3
“We speculate that the considerably lower FFA level in SIRD could indicate a reasonably effective insulin action in the prevention of lipolysis [28].”
The Lipotoxicity and Glucotoxicity Hypothesis in the Metabolic Syndrome and Type 2 Diabetes
Dimitriadis, G., Boutati, E. I., & Raptis, S. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50016-4 · Cited by 3
Determining the Factors that Influence the Insulin Requirements in Type 2 Diabetic Patients
Chung, J. O., Cho, D. H., Chung, D. J., & Chung, M. Y. (2010) · Endocrinology and Metabolism · doi:10.3803/enm.2010.25.2.110 · Cited by 3
Monnier, L., Halimi, S., & Bonnet, F. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30010-4 · Cited by 2
Gül, N., Cebesoy, S., Özsoy, N., Eskizengin, H., & Özer, Ç. (2022) · Microscopy and Microanalysis · doi:10.1017/s143192762201251x · Cited by 2
Metadata
- Authors
- Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- University of Helsinki (FI)
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 205-213
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303971
- OpenAlex
- W1981456793
- Cited by
- 812
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 28 · 2023: 15 · 2022: 27 · 2021: 30 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 32 · 2016: 26 · 2015: 22 · 2014: 22 · 2013: 26 · 2012: 26
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- Fogarty International Center (F05-TWO-3451)
- National Center for Research Resources (RR 125)
- Ministero dell'Istruzione e del Merito
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- type 2 diabetes, insulin resistance, glucose metabolism, free fatty acid metabolism, hepatic glucose production, glucose oxidation, nonoxidative glucose metabolism, fatty acid oxidation, fatty acid re-esterification, hyperinsulinemia, insulin clamp, lipid oxidation
- MeSH terms
- Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Oxidation-Reduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.